Myasthenia Gravis Foundation of America Launches MGFA Food Support Program to Advance Nutrition Access and Health Equity for Individuals with Myasthenia Gravis
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science [TheStreet.com]
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
UCB (UCBJY) was upgraded by Zacks Research from "hold" to "strong-buy".
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting [TheStreet.com]